Karlyn D Beer1, Sarah A Collier1, Fan Du2, Julia W Gargano3. 1. Division of Foodborne, Waterborne and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 2. Human-Computer Interaction Lab, University of Maryland, College Park, USA. 3. Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Abstract
Background: Giardiasis, the most common enteric parasitic infection in the United States, causes an estimated 1.2 million episodes of illness annually. Published clinical recommendations include readily available Giardia-specific diagnostic testing and antiparasitic drugs. We investigated sequences of giardiasis diagnostic and treatment events using MarketScan, a large health insurance claims database. Methods: We created a longitudinal cohort of 2995 persons diagnosed with giardiasis (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] code 007.1) from 2006 to 2010, and analyzed claims occurring 90 days before to 90 days after initial diagnosis. We evaluated differences in number and sequence of visits, diagnostic tests, and prescriptions by age group (children 1-17 years, adults 18-64 years) using χ2 tests and data visualization software. Results: Among 2995 patients (212433 claims), 18% had a Giardia-specific test followed by or concurrent with an effective antiparasitic drug, without ineffective antibiotics. Almost two-thirds of patients had an antiparasitic and 27% had an antibiotic during the study window. Compared with children, adults more often had ≥3 visits before diagnosis (19% vs 15%; P = .02). Adults were also less likely to have a Giardia-specific diagnostic test (48% vs 58%; P < .001) and more likely to have an antibiotic prescription (28% vs 25%; P = .04). When Giardia-specific tests and antiparasitic and antibiotic prescriptions were examined, pediatric clinical event sequences most frequently began with a Giardia-specific test, whereas adult sequences most frequently began with an antiparasitic prescription. Conclusions: Giardiasis care infrequently follows all aspects of clinical recommendations. Multiple differences between pediatric and adult care, despite age-agnostic recommendations, suggest opportunities for provider education or tailored guidance. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Background: Giardiasis, the most common enteric parasitic infection in the United States, causes an estimated 1.2 million episodes of illness annually. Published clinical recommendations include readily available Giardia-specific diagnostic testing and antiparasitic drugs. We investigated sequences of giardiasis diagnostic and treatment events using MarketScan, a large health insurance claims database. Methods: We created a longitudinal cohort of 2995 persons diagnosed with giardiasis (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] code 007.1) from 2006 to 2010, and analyzed claims occurring 90 days before to 90 days after initial diagnosis. We evaluated differences in number and sequence of visits, diagnostic tests, and prescriptions by age group (children 1-17 years, adults 18-64 years) using χ2 tests and data visualization software. Results: Among 2995 patients (212433 claims), 18% had a Giardia-specific test followed by or concurrent with an effective antiparasitic drug, without ineffective antibiotics. Almost two-thirds of patients had an antiparasitic and 27% had an antibiotic during the study window. Compared with children, adults more often had ≥3 visits before diagnosis (19% vs 15%; P = .02). Adults were also less likely to have a Giardia-specific diagnostic test (48% vs 58%; P < .001) and more likely to have an antibiotic prescription (28% vs 25%; P = .04). When Giardia-specific tests and antiparasitic and antibiotic prescriptions were examined, pediatric clinical event sequences most frequently began with a Giardia-specific test, whereas adult sequences most frequently began with an antiparasitic prescription. Conclusions: Giardiasis care infrequently follows all aspects of clinical recommendations. Multiple differences between pediatric and adult care, despite age-agnostic recommendations, suggest opportunities for provider education or tailored guidance. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Entities:
Keywords:
Giardia; MarketScan; administrative claims; data visualization
Authors: Bruce E Sands; Mei-Sheng Duh; Clorinda Cali; Anuli Ajene; Rhonda L Bohn; David Miller; J Alexander Cole; Suzanne F Cook; Alexander M Walker Journal: Pharmacoepidemiol Drug Saf Date: 2006-01 Impact factor: 2.890
Authors: Sarah L Goff; Andrew Feld; Susan E Andrade; Lisa Mahoney; Sarah J Beaton; Denise M Boudreau; Robert L Davis; Michael Goodman; Cynthia L Hartsfield; Richard Platt; Douglas Roblin; David Smith; Marianne Ulcickas Yood; Katherine Dodd; Jerry H Gurwitz Journal: J Clin Epidemiol Date: 2008-03-04 Impact factor: 6.437
Authors: Aron J Hall; Mariana Rosenthal; Nicole Gregoricus; Sharon A Greene; Jeana Ferguson; Olga L Henao; Jan Vinjé; Ben A Lopman; Umesh D Parashar; Marc-Alain Widdowson Journal: Emerg Infect Dis Date: 2011-08 Impact factor: 6.883
Authors: Brian I Grajeda; Atasi De Chatterjee; Carmen M Villalobos; Breanna C Pence; Cameron C Ellis; Vanessa Enriquez; Sourav Roy; Sukla Roychowdhury; Aaron K Neumann; Igor C Almeida; Steven E Patterson; Siddhartha Das Journal: Front Cell Infect Microbiol Date: 2022-08-23 Impact factor: 6.073